Your browser doesn't support javascript.
loading
Apatinib plus camrelizumab (anti-PD1 therapy, SHR-1210) for advanced osteosarcoma (APFAO) progressing after chemotherapy: a single-arm, open-label, phase 2 trial.
Xie, Lu; Xu, Jie; Sun, Xin; Guo, Wei; Gu, Jin; Liu, Kuisheng; Zheng, Bingxin; Ren, Tingting; Huang, Yi; Tang, Xiaodong; Yan, Taiqiang; Yang, Rongli; Sun, Kunkun; Shen, Danhua; Li, Yuan.
Afiliação
  • Xie L; Musculoskeletal Tumor Center, Peking University People's Hospital, Beijing, China.
  • Xu J; Musculoskeletal Tumor Center, Peking University People's Hospital, Beijing, China.
  • Sun X; Musculoskeletal Tumor Center, Peking University People's Hospital, Beijing, China.
  • Guo W; Musculoskeletal Tumor Center, Peking University People's Hospital, Beijing, China bonetumor@163.com.
  • Gu J; Surgical Oncology, Peking University Shougang Hospital, Beijing, China.
  • Liu K; Musculoskeletal Tumor Center, Peking University People's Hospital, Beijing, China.
  • Zheng B; Musculoskeletal Tumor Center, Peking University People's Hospital, Beijing, China.
  • Ren T; Musculoskeletal Tumor Center, Peking University People's Hospital, Beijing, China.
  • Huang Y; Musculoskeletal Tumor Center, Peking University People's Hospital, Beijing, China.
  • Tang X; Musculoskeletal Tumor Center, Peking University People's Hospital, Beijing, China.
  • Yan T; Musculoskeletal Tumor Center, Peking University People's Hospital, Beijing, China.
  • Yang R; Musculoskeletal Tumor Center, Peking University People's Hospital, Beijing, China.
  • Sun K; Pathology Department, Peking University People's Hospital, Beijing, China.
  • Shen D; Pathology Department, Peking University People's Hospital, Beijing, China.
  • Li Y; Radiology Department & Nuclear Medicine Department, Peking University People's Hospital, Beijing, China.
J Immunother Cancer ; 8(1)2020 05.
Article em En | MEDLINE | ID: mdl-32376724

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piridinas / Neoplasias Ósseas / Protocolos de Quimioterapia Combinada Antineoplásica / Osteossarcoma / Anticorpos Monoclonais Humanizados Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piridinas / Neoplasias Ósseas / Protocolos de Quimioterapia Combinada Antineoplásica / Osteossarcoma / Anticorpos Monoclonais Humanizados Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article